SCHEMBL17849587

SCHEMBL17849587

C=C1C=Cc2cccnc2O1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6852823 0.78 CA12 (0.47) CA12CA1CA2CA9
SCHEMBL17849602 0.72 CA12 (0.34) CA12CA1CA2CA9
SCHEMBL30912244 0.70 MEN1 (0.48)
SCHEMBL8105009 0.68 CA12 (0.42) CA12CA1CA2CA9
SCHEMBL17849590 0.67 TRPA1 (0.33) CA12CA1CA2CA9
SCHEMBL20243935 0.66
SCHEMBL16020287 0.66
SCHEMBL19810744 0.66 CA12 (0.37) CA12CA1CA2CA9
SCHEMBL5033603 0.66
SCHEMBL9099675 0.64 TRPA1 (0.61) CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371336-B2 Compounds for treating spinal muscular atrophy PTC THERAPEUTICS, INC. (US) 2016-06-21 US disclosed